PANEL ON LIVER DISEASES
Albert M. Snell, M.D., Palo Alto, Calif.
Robert Kark, M.D., Chicago Hugh R. Butt, M.D., Rochester, Minn. Victor Sborov, M.D., San Francisco C. M. Jones, M.D., Boston
The questions to be considered by this panel fall into four groups: (1) the place of diet and drugs in the treatment of liver disease; (2) infectious hepatitis and its consequences; (3) the nature, clinical recognition, and management of hepatic insufficiency; and (4) the control of hemorrhage from esophageal varices. We are asked to discuss first the type of diet to be recommended for a patient with atrophic cirrhosis.
By the term atrophic cirrhosis, I assume that one means chronic liver disease secondary to those degenerative processes that appear to be due to a diet inadequate in total calories and more particularly in protein content. The term might also be used to designate the